Eriacta: Pharmaceutical Insights

Product Name Active Ingredient Dosage Form Administration
Eriacta Sildenafil Citrate 100 mg Tablet Oral
Visit Eriacta Site

Chemical Structure

Eriacta, comprising sildenafil citrate 100 mg, serves as a phosphodiesterase type 5 (PDE5) inhibitor. Its chemical structure includes a pyrazolo[4,3-d]pyrimidin-7-one skeleton. This structural configuration allows the molecule to engage effectively with PDE5. Key functional groups within sildenafil promote selectivity and efficacy. The benzene sulfonamide moiety ensures interaction at specific enzymatic sites. Meanwhile, the ethyl group provides the necessary solubility and permeability.

The hydrophobic and hydrophilic balance enhances pharmacokinetic properties. Such a balance permits the drug’s activity at the target site. Complex bonding arrangements within sildenafil confer its unique attributes. Precise arrangement facilitates inhibition of cyclic guanosine monophosphate (cGMP) degradation. This underpins its clinical application in erectile dysfunction.

Mechanism of Action

Eriacta exerts its pharmacological effects by targeting PDE5. Inhibition of PDE5 results in elevated cGMP levels in the corpus cavernosum. This elevation occurs through blockade of cGMP hydrolysis. Elevated cGMP levels promote smooth muscle relaxation. This relaxation facilitates increased blood flow.

The sequence begins with nitric oxide (NO) release during sexual stimulation. NO activates guanylate cyclase, increasing cGMP synthesis. Eriacta enhances this pathway by inhibiting PDE5. Consequently, improved erectile response manifests. It maintains efficacy by preserving NO-mediated effects.

Warnings & Precautions

Caution must be observed with Eriacta. Patients with cardiovascular disease require assessment before use. Interaction with nitrate therapy can provoke severe hypotension. Patients should be advised to avoid concomitant nitrate medication.

Visual disturbances and hearing loss have been reported. Discontinue Eriacta if these symptoms arise. Patients with retinitis pigmentosa should avoid sildenafil. Monitor those with renal or hepatic impairment. The drug may require dose adjustments in such populations.

Missed Dose

Eriacta is administered as needed. It is not for daily use. If a dose is missed, take it when remembered. Ensure timing aligns with anticipated sexual activity. Avoid doubling doses if the next intake is imminent.

Timing and dosing are crucial. Adherence to prescribed dosing schedules maximizes efficacy. Take Eriacta approximately 30 minutes to four hours before activity. Adjust timing based on individual response.

Signs and Symptoms of Overdose

Overdose of Eriacta can cause significant adverse effects. Symptoms include severe headache, dizziness, and vision changes. Prolonged erections exceeding four hours may occur.

Seek immediate medical attention for priapism. Prompt intervention can prevent lasting damage. Supportive treatment addresses symptomatic concerns. No specific antidote exists for sildenafil overdose.

Purchase Without Prescription

Acquiring Eriacta without a prescription presents risks. Quality assurance may be compromised. Counterfeit medications pose serious health threats. Ensure authenticity through verified channels.

Online purchases must be approached with caution. Verify the legitimacy of sources. Unauthorized transactions may lead to unsafe product consumption.

  • Verify product authenticity.
  • Consult healthcare professionals before use.
  • Follow regulatory guidelines for safe purchase.

Eriacta remains a valuable pharmaceutical intervention. Adhering to safety guidelines ensures optimal therapeutic outcomes. Responsible use aligns with health objectives. Prioritize safe and informed decisions for sildenafil use.

Data source:

Scroll to Top